Cue Biopharma CFO James M. Ahlers files initial beneficial ownership statement
CUE•Form 3 filing
- Cue Biopharma CFO James M. Ahlers filed an initial Form 3 statement of beneficial ownership dated July 30, 2026.
Related News
Highland Opportunities and Income Fund declares $0.0385 monthly distribution
HFRO•
Palantir lifts annual revenue forecast as data analytics spending booms
PLTR•
Paccar CEO Preston Feight sells 50,975 shares for $6.78 million
PCAR•
Northern Trust to redeem Series D preferred depositary shares at USD 1,000 each on Oct. 1, 2026
NTRS•
Datadog director Amit Agarwal reports disposal of 20,000 common shares valued at $5.04 million
DDOG•